BioPharma Drug Discovery
Harbour BioMed and Otsuka Ink $670M+ Global Deal to Advance Bispecific T-Cell Engager for Autoimmune Diseases
Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology,&nb...
June 23, 2025 | News
XtalPi and DoveTree Sign $100M+ LOI to Accelerate AI-Driven Drug Discovery Across Oncology and Neurology
XtalPi, a global leader in AI- and robotics-powered drug and materials discovery, announced it has signed a Letter of Intent (LOI) with DoveTre...
June 23, 2025 | News
Veranova Invests Over $50M to Launch Bioconjugation Development and GMP Manufacturing in Massachusetts
Veranova, a global leader in the development and manufacturing of specialist and complex active pharmaceutical ingredients (APIs) for the pha...
June 19, 2025 | News
NEC and Chugai Harness AI to Halve Time Needed for Predicting Effective Cancer Drug Combinations
Identified the potential to reduce the time required to research and predict drug combinations by approximately 50% NEC Corporation (NEC; TSE: ...
June 19, 2025 | News
Thermo Fisher’s Integrated CDMO-CRO Model Cuts Drug Development Time by Up to 34 Months, Finds Tufts CSDD Study
Thermo Fisher Scientific Inc., the world leader in serving science, announced the findings of new research by the Tufts Center for the Study of Drug ...
June 17, 2025 | News
Sweden’s Salipro Biotech Partners with South Korea’s Daewoong Pharmaceutical to Target Challenging Drug Discovery
- The collaboration combines Salipro Biotech's unique expertise and its Salipro® platform technology to stabilize a challenging drug target and advance...
June 12, 2025 | News
Deep Apple Therapeutics and Novo Nordisk Join Forces to Develop Next-Gen Oral Therapies for Cardiometabolic Diseases
- Deep Apple Therapeutics Announces Collaboration with Novo Nordisk to Discover and Develop Oral Therapies for Cardiometabolic Diseases The partnership ai...
June 12, 2025 | News
Insilico Medicine and AWS Bring Nach01 Generative AI Model for Drug Discovery to Global Researchers via AWS Marketplace
Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), announced the recent release of its Nach...
June 11, 2025 | News
Harrow Secures Exclusive U.S. Rights to BYQLOVI for Post-Surgical Eye Care Following FDA Approval
Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, and Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW), today a...
June 10, 2025 | News
Innovent and HUTCHMED’s Sintilimab-Fruquintinib Combo Accepted for NMPA Review in Advanced Renal Cell Carcinoma
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...
June 05, 2025 | News
JW Therapeutics Secures Macao Approval for CAR-T Therapy Carteyva®, Marking First Overseas Market Entry
JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunother...
June 05, 2025 | News
Akeso’s Cadonilimab Secures NMPA Approval for First-Line Treatment of Cervical Cancer
Akeso, Inc. is pleased to announce that the National Medical Products Administration (NMPA) has approved the company's first- in-class PD-1/CTLA-4 bispecif...
June 05, 2025 | News
Singapore Approves Astellas’ VEOZA™ (Fezolinetant) for Moderate to Severe Menopausal Vasomotor Symptoms
Astellas Singapore has announced that the Health Sciences Authority (HSA) of Singapore has approved VEOZA™ (fezolinetant) 45 mg for the treatment of ...
June 04, 2025 | News
Thermo Fisher Launches Orbitrap Astral Zoom and Excedion Pro MS to Accelerate Precision Research in Alzheimer's, Cancer, and Biopharma
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced the launch of the Thermo Scientific™ Orbitrap™ ...
June 03, 2025 | News
Most Read
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
